{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:05:49Z","timestamp":1790111149161,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-10129-w","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T07:01:42Z","timestamp":1692428502000},"page":"1016-1025","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Myocardial extracellular volume quantification in cardiac amyloidosis: a comparative study between cardiac computed tomography and magnetic resonance imaging"],"prefix":"10.1007","volume":"34","author":[{"given":"Hidetaka","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4101-5113","authenticated-orcid":false,"given":"Seitaro","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kidoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinpei","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Takashio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Usuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nakaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuharu","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,19]]},"reference":[{"key":"10129_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1182\/blood-2018-06-858951","volume":"133","author":"B Lilleness","year":"2019","unstructured":"Lilleness B, Ruberg FL, Mussinelli R, Doros G, Sanchorawala V (2019) Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis. Blood 133:215\u2013223","journal-title":"Blood"},{"key":"10129_CR2","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","volume":"39","author":"JD Gillmore","year":"2018","unstructured":"Gillmore JD, Damy T, Fontana M et al (2018) A new staging system for cardiac transthyretin amyloidosis. Eur Heart J 39:2799\u20132806","journal-title":"Eur Heart J"},{"key":"10129_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jaccao.2020.06.007","volume":"2","author":"RK Cheng","year":"2020","unstructured":"Cheng RK, Levy WC, Vasbinder A et al (2020) Diuretic dose and NYHA functional class are independent predictors of mortality in patients with transthyretin cardiac amyloidosis. JACC CardioOncol 2:414\u2013424","journal-title":"JACC CardioOncol"},{"key":"10129_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","volume":"2","author":"SF Mohammed","year":"2014","unstructured":"Mohammed SF, Mirzoyev SA, Edwards WD et al (2014) Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2:113\u2013122","journal-title":"JACC Heart Fail"},{"key":"10129_CR5","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jacep.2020.04.019","volume":"6","author":"E Donnellan","year":"2020","unstructured":"Donnellan E, Wazni OM, Hanna M et al (2020) Atrial fibrillation in transthyretin cardiac amyloidosis: predictors, prevalence, and efficacy of rhythm control strategies. JACC Clin Electrophysiol 6:1118\u20131127","journal-title":"JACC Clin Electrophysiol"},{"key":"10129_CR6","doi-asserted-by":"publisher","first-page":"e005066","DOI":"10.1161\/CIRCIMAGING.116.005066","volume":"9","author":"TA Treibel","year":"2016","unstructured":"Treibel TA, Fontana M, Gilbertson JA et al (2016) Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement. Circ Cardiovasc Imaging 9:e005066","journal-title":"Circ Cardiovasc Imaging"},{"key":"10129_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1056\/NEJMoa2028631","volume":"385","author":"E Kastritis","year":"2021","unstructured":"Kastritis E, Palladini G, Minnema MC et al (2021) Daratumumab-based treatment for immunoglobulin light-chain amyloidosis. N Engl J Med 385:46\u201358","journal-title":"N Engl J Med"},{"key":"10129_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jchf.2020.09.011","volume":"9","author":"C Rapezzi","year":"2021","unstructured":"Rapezzi C, Elliott P, Damy T et al (2021) Efficacy of tafamidis in patients with hereditary and wild-type transthyretin amyloid cardiomyopathy: further analyses from ATTR-ACT. JACC Heart Fail 9:115\u2013123","journal-title":"JACC Heart Fail"},{"key":"10129_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams D, Gonzalez-Duarte A, O\u2019Riordan WD et al (2018) Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med 379:11\u201321","journal-title":"N Engl J Med"},{"key":"10129_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1716793","volume":"379","author":"MD Benson","year":"2018","unstructured":"Benson MD, Waddington-Cruz M, Berk JL et al (2018) Inotersen treatment for patients with hereditary transthyretin amyloidosis. N Engl J Med 379:22\u201331","journal-title":"N Engl J Med"},{"key":"10129_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1148\/rg.2020190069","volume":"40","author":"S Oda","year":"2020","unstructured":"Oda S, Kidoh M, Nagayama Y et al (2020) Trends in diagnostic imaging of cardiac amyloidosis: emerging knowledge and concepts. Radiographics 40:961\u2013981","journal-title":"Radiographics"},{"key":"10129_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12968-017-0419-6","volume":"20","author":"L Lin","year":"2018","unstructured":"Lin L, Li X, Feng J et al (2018) The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis. J Cardiovasc Magn Reson 20:2","journal-title":"J Cardiovasc Magn Reson"},{"key":"10129_CR13","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","volume":"12","author":"A Martinez-Naharro","year":"2019","unstructured":"Martinez-Naharro A, Kotecha T, Norrington K et al (2019) Native T1 and extracellular volume in transthyretin amyloidosis. JACC Cardiovasc Imaging 12:810\u2013819","journal-title":"JACC Cardiovasc Imaging"},{"key":"10129_CR14","first-page":"e000030","volume":"14","author":"S Dorbala","year":"2021","unstructured":"Dorbala S, Ando Y, Bokhari S et al (2021) ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization. Circ Cardiovasc Imaging 14:e000030","journal-title":"Circ Cardiovasc Imaging"},{"key":"10129_CR15","doi-asserted-by":"crossref","unstructured":"Oda S, Emoto T, Nakaura T et al (2019) Myocardial late iodine enhancement and extracellular volume quantification with dual-layer spectral detector dual-energy cardiac CT. Radiol Cardiothorac Imaging 1:e180003","DOI":"10.1148\/ryct.2019180003"},{"key":"10129_CR16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00330-019-06418-y","volume":"30","author":"T Emoto","year":"2020","unstructured":"Emoto T, Kidoh M, Oda S et al (2020) Myocardial extracellular volume quantification in cardiac CT: comparison of the effects of two different iterative reconstruction algorithms with MRI as a reference standard. Eur Radiol 30:691\u2013701","journal-title":"Eur Radiol"},{"key":"10129_CR17","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.jcmg.2022.08.006","volume":"15","author":"F Gama","year":"2022","unstructured":"Gama F, Rosmini S, Bandula S et al (2022) Extracellular volume fraction by computed tomography predicts long-term prognosis among patients with cardiac amyloidosis. JACC Cardiovasc Imaging 15:2082\u20132094","journal-title":"JACC Cardiovasc Imaging"},{"key":"10129_CR18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1148\/radiol.2021204192","volume":"300","author":"JF Deux","year":"2021","unstructured":"Deux JF, Nouri R, Tacher V et al (2021) Diagnostic value of extracellular volume quantification and myocardial perfusion analysis at CT in cardiac amyloidosis. Radiology 300:326\u2013335","journal-title":"Radiology"},{"key":"10129_CR19","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","volume":"42","author":"P Garcia-Pavia","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y et al (2021) Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 42:1554\u20131568","journal-title":"Eur Heart J"},{"key":"10129_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jcct.2016.02.001","volume":"10","author":"Y Kurita","year":"2016","unstructured":"Kurita Y, Kitagawa K, Kurobe Y et al (2016) Estimation of myocardial extracellular volume fraction with cardiac CT in subjects without clinical coronary artery disease: a feasibility study. J Cardiovasc Comput Tomogr 10:237\u2013241","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10129_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15:155\u2013163","journal-title":"J Chiropr Med"},{"key":"10129_CR22","doi-asserted-by":"publisher","first-page":"e010358","DOI":"10.1161\/CIRCIMAGING.119.010358","volume":"13","author":"S Oda","year":"2020","unstructured":"Oda S, Kidoh M, Takashio S et al (2020) Quantification of myocardial extracellular volume with planning computed tomography for transcatheter aortic valve replacement to identify occult cardiac amyloidosis in patients with severe aortic stenosis. Circ Cardiovasc Imaging 13:e010358","journal-title":"Circ Cardiovasc Imaging"},{"key":"10129_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.119.010261","volume":"13","author":"S Oda","year":"2020","unstructured":"Oda S, Kidoh M, Takashio S et al (2020) Identification of wild-type transthyretin cardiac amyloidosis by quantifying myocardial extracellular volume using cardiac computed tomography in atrial arrhythmias. Circ Cardiovasc Imaging 13:e010261","journal-title":"Circ Cardiovasc Imaging"},{"key":"10129_CR24","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1148\/radiol.12112458","volume":"264","author":"MS Nacif","year":"2012","unstructured":"Nacif MS, Kawel N, Lee JJ et al (2012) Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT. Radiology 264:876\u2013883","journal-title":"Radiology"},{"key":"10129_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1148\/radiol.14140131","volume":"274","author":"R Jablonowski","year":"2015","unstructured":"Jablonowski R, Wilson MW, Do L, Hetts SW, Saeed M (2015) Multidetector CT measurement of myocardial extracellular volume in acute patchy and contiguous infarction: validation with microscopic measurement. Radiology 274:370\u2013378","journal-title":"Radiology"},{"key":"10129_CR26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1148\/radiol.13130130","volume":"269","author":"S Bandula","year":"2013","unstructured":"Bandula S, White SK, Flett AS et al (2013) Measurement of myocardial extracellular volume fraction by using equilibrium contrast-enhanced CT: validation against histologic findings. Radiology 269:396\u2013403","journal-title":"Radiology"},{"key":"10129_CR27","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jcct.2015.07.001","volume":"9","author":"TA Treibel","year":"2015","unstructured":"Treibel TA, Bandula S, Fontana M et al (2015) Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis. J Cardiovasc Comput Tomogr 9:585\u2013592","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10129_CR28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.diii.2021.03.003","volume":"102","author":"B Dubourg","year":"2021","unstructured":"Dubourg B, Dacher JN, Durand E et al (2021) Single-source dual energy CT to assess myocardial extracellular volume fraction in aortic stenosis before transcatheter aortic valve implantation (TAVI). Diagn Interv Imaging 102:561\u2013570","journal-title":"Diagn Interv Imaging"},{"key":"10129_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1148\/radiol.2016151289","volume":"280","author":"HJ Lee","year":"2016","unstructured":"Lee HJ, Im DJ, Youn JC et al (2016) Myocardial extracellular volume fraction with dual-energy equilibrium contrast-enhanced cardiac CT in nonischemic cardiomyopathy: a prospective comparison with cardiac MR imaging. Radiology 280:49\u201357","journal-title":"Radiology"},{"key":"10129_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"DR Messroghli","year":"2017","unstructured":"Messroghli DR, Moon JC, Ferreira VM et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19:75","journal-title":"J Cardiovasc Magn Reson"},{"key":"10129_CR31","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1253\/circj.CJ-20-0110","volume":"84","author":"H Kitaoka","year":"2020","unstructured":"Kitaoka H, Izumi C, Izumiya Y et al (2020) JCS 2020 Guideline on Diagnosis and Treatment of Cardiac Amyloidosis. Circ J 84:1610\u20131671","journal-title":"Circ J"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10129-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-10129-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10129-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T11:09:00Z","timestamp":1707390540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-10129-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,19]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["10129"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-10129-w","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,19]]},"assertion":[{"value":"27 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Prof. Toshinori Hirai, Kumamoto University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"We have no direct or indirect financial interest in the products used or the subject matter discussed in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 Retrospective\u2022 diagnostic study\u2022 performed at one institution","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}